Co. has cash on hand and it's a more effective way, in my view, than a buyback, to aggravate the boys from Boca and others that are in the game. Even a $0.10 dividend would hurt, particularly if they could project that for the future and not just a one time 'special' dividend. Perhaps that's why the stock has performed better relative to IBB in general? Earnings will be a blow out. Weather has been fab and sales won't suffer from cancelled procedures.
Candy--of course it 'works'--whatever that means. If true, it will be money you have to come up with or utilize a LOC for. Of course it won't harm the big guys with deep credit lines. But it just might affect some others. In any event, a sure sign of a growing company.
Exactly. And you can bet shortie knows exactly what the rescheduling means. "After industry and thought leader input we have reassessed our draft guidance". I can see it now; just wish we wouldn't have to wait a year. Time will tell; I can only imagine the horsetrading behind the new FDA appointment.